Browse the evidence

Patients with type 2 diabetes lose approximately half the weight achieved by non-diabetic patients through dietary counseling, and studies excluding diabetic patients report greater net weight loss.

If you have type 2 diabetes, expect to lose about half as much weight as a non-diabetic person following the same dietary counseling program. This is a known physiological difference, not a failure on your part. Focus on the health benefits of even modest weight loss.

Higher cardiorespiratory fitness (CRF) is inversely associated with all-cause mortality with no observed upper limit of benefit, meaning extreme fitness levels provide greater survival advantages than moderate fitness.

Focus on improving your cardiorespiratory fitness through aerobic exercise. This study shows that higher fitness levels correlate with significantly lower mortality risk, and there is no 'ceiling' where more fitness becomes harmful. Even if you have conditions like hypertension, achieving high fitness levels offers significant survival advantages.

Intravenous administration of exendin-4 (0.05 pmol/kg/min) significantly reduces fasting and postprandial plasma glucose levels and decreases caloric intake by 19% in healthy volunteers without causing nausea.

Exendin-4, a GLP-1 receptor agonist, significantly lowers blood glucose and reduces calorie intake in healthy individuals without causing nausea at the tested dose. It works by delaying gastric emptying and reducing hunger, offering a potential treatment for type 2 diabetes and obesity.

A higher Triglyceride-Glucose (TyG) index is independently associated with an increased incidence of atherosclerotic cardiovascular diseases (ASCVD), coronary artery disease (CAD), and stroke in individuals without baseline ASCVD.

If you are getting standard blood work, ask for your fasting glucose and triglyceride levels. You can calculate your TyG index using the formula: ln[triglycerides (mg/dL) × fasting plasma glucose (mg/dL) / 2]. A higher result indicates higher insulin resistance and a statistically higher risk for heart disease and stroke, even if your cholesterol looks normal. Discuss this with your doctor as part of a broader cardiovascular risk assessment.

Dietary composition (specifically fiber and carbohydrate content) is the primary driver of gut microbiota composition and functional metabolic output, overriding genetic background in shaping enterotypes.

Focus on long-term dietary patterns, specifically increasing fiber and complex carbohydrates, to support a diverse microbiota. While you may not change your 'enterotype' overnight, your gut microbes will rapidly adjust their functional output (gene expression) to process the food you eat. Prioritize plant-based fibers to encourage beneficial bacteria like Prevotella and Bacteroidetes.

Motivational Interviewing (MI) and avoiding stigmatization are critical components of obesity management that improve patient adherence, self-esteem, and treatment efficacy.

Work with your doctor to build a trusting relationship. Use Motivational Interviewing techniques to identify your own reasons for wanting to change. Focus on small, realistic goals and celebrate progress in health, not just weight.

Dietary intake of omega-3 fatty acids (approx. 1.5 g/day) modestly mitigates the progression of coronary atherosclerosis and promotes regression in patients with established coronary artery disease over a 2-year period.

If you have coronary artery disease, taking approximately 1.5 grams of omega-3 fatty acids daily (from fish oil) for two years can help slow the progression of plaque buildup in your arteries and may even encourage some regression. This benefit occurs even if your LDL cholesterol levels rise slightly, suggesting the mechanism works directly on the artery walls or blood flow rather than just cholesterol levels. Consult your doctor before starting, especially given the dosage.

While HP-HMB supplementation significantly reduces mortality and improves nutritional status (SGA class) and body weight at 30 days, it does not significantly reduce the rate of nonelective hospital readmission in malnourished older adults.

If you are an older adult hospitalized for heart or lung issues and are malnourished, using a high-protein HMB supplement will likely help you gain weight and improve your nutritional status, and it may save your life. However, you should not expect it to prevent hospital readmissions on its own.

Exposure to digital images of appetizing food (visual hunger) triggers neural, physiological, and attentional responses that increase food craving and consumption, potentially exacerbating obesity.

Be aware that scrolling through food images on social media or watching cooking shows can trigger physiological hunger responses and increase your likelihood of overeating when you do consume food. If you are trying to manage your weight, consider limiting exposure to highly appetizing food imagery, especially when you are already hungry.

EPA-only prescription omega-3s (Icosapent Ethyl) do not raise LDL cholesterol in patients with very high triglycerides, whereas EPA+DHA combinations may increase LDL-C by 15-36%.

If you are taking prescription omega-3s for high triglycerides, ask your doctor if your medication contains only EPA or both EPA and DHA. EPA-only options (like Vascepa) do not raise your LDL ('bad') cholesterol, whereas combinations (like Lovaza) might increase it by 15-36%. This distinction is important for your overall cardiovascular risk.

Individuals with prediabetes exhibit an aberrant gut microbiota profile characterized by a significant depletion of the genus Clostridium and the mucin-degrading bacterium Akkermansia muciniphila, which correlates with markers of poor metabolic health.

If you have prediabetes, your gut bacteria likely look different than those of someone with normal glucose regulation, specifically showing lower levels of beneficial bacteria like Akkermansia and Clostridium. While this is a strong indicator of metabolic stress, simply changing your diet to target these bacteria may not be enough to reverse insulin resistance without addressing broader metabolic factors, as the microbiota change alone does not appear to cause the glucose intolerance in animal models.

Individuals with high scores on the Ford Insomnia Response to Stress Test (FIRST) exhibit significantly lower sleep efficiency and increased sleep latency during a first night in the laboratory compared to those with low scores, indicating a trait vulnerability to stress-related sleep disturbance.

If you find that stressful events consistently ruin your sleep, you may have a physiological trait called 'stress-related vulnerability.' This isn't a character flaw; it's a predisposition. Understanding this can help you manage expectations and seek targeted interventions (like stress management techniques) rather than just blaming yourself for poor sleep hygiene.

Weakness combined with normal lean mass still carries a high risk of mobility impairment, suggesting that muscle quality (function) is distinct from muscle quantity (mass).

You can have normal muscle size but still be 'weak' and at high risk for mobility issues. This is often due to muscle quality (fat infiltration, nerve function) rather than size. Strength training can improve function even if muscle size doesn't change dramatically.

Low skeletal muscle mass (sarcopenia) in elderly ICU patients is significantly associated with increased mortality, decreased ventilator-free days, and decreased ICU-free days, whereas traditional nutritional markers like BMI and serum albumin are not predictive of these outcomes.

For elderly trauma patients, standard weight checks (BMI) and blood tests (albumin) are insufficient to assess risk. Measuring skeletal muscle mass via CT scans at admission is critical for identifying high-risk patients who may need aggressive nutritional and rehabilitative support to improve survival and reduce ICU stay.

Self-reported physical activity questionnaires (IPAQ) significantly underestimate the strength of the relationship between moderate-to-vigorous physical activity (MVPA) and metabolic risk biomarkers (insulin, triglycerides, HOMA-IR) compared to objective accelerometer measurements.

If you are using a fitness tracker, trust its data on metabolic health more than your memory of how much you moved. Self-reporting tends to overestimate activity and underestimate its health benefits. For precise health risk assessment, objective measurement is superior.

Continuous positive airway pressure (CPAP) therapy significantly reduces subjective and objective daytime sleepiness in patients with obstructive sleep apnea (OSA) compared to placebo.

If you have obstructive sleep apnea, using CPAP therapy nightly will significantly reduce your daytime sleepiness compared to doing nothing or using a placebo treatment. This benefit is most pronounced if your sleep apnea is severe. While previous reviews questioned its effectiveness, current evidence from multiple randomized trials confirms CPAP works to improve both how sleepy you feel and objective sleep tests.

Patients with severe obstructive sleep apnea (AHI >= 30) and significant baseline sleepiness (ESS >= 11) experience a significantly greater reduction in sleepiness from CPAP therapy than patients with milder symptoms.

If you have severe sleep apnea and feel very sleepy during the day, CPAP is likely to make a dramatic difference in your energy levels. For those with milder symptoms, the improvement in sleepiness might be minimal or unnoticeable, though CPAP may still be recommended for other health reasons.

Living in neighborhoods with fewer supermarkets and more fast-food restaurants increases the likelihood of obesity in ethnic minority and low-income children due to reduced access to affordable, healthful foods and increased availability of energy-dense options.

In low-income and minority neighborhoods, access to fresh, affordable food is often limited, and fast-food options are abundant. To mitigate this, support or advocate for school programs that provide free or low-cost fruits and vegetables. Encourage families to utilize any available supermarkets, even if fewer, and be aware that corner stores may have higher prices for healthy items. Policy interventions to increase supermarket availability and restrict fast-food density are critical.

High plasma levels of alpha2-Heremans-Schmid glycoprotein (AHSG/fetuin-A) are associated with insulin resistance and hepatic fat accumulation in humans, and high baseline AHSG predicts a blunted improvement in insulin sensitivity following lifestyle intervention.

High levels of a liver-derived protein called AHSG are linked to insulin resistance and fatty liver. While you don't need to test for AHSG, the study shows that reducing liver fat through lifestyle changes (diet and exercise) lowers AHSG levels. Therefore, interventions that specifically target liver fat accumulation may improve insulin sensitivity more effectively, as high baseline AHSG predicts a slower improvement in sensitivity.

Shift work, particularly night shifts, disrupts circadian-aligned metabolism, leading to impaired glucose tolerance, elevated triglycerides, and increased cardiovascular risk due to nocturnal eating and sleep deprivation.

If you work night shifts, prioritize lighter, lower-fat meals during the night and save heavier, nutrient-dense meals for your post-shift sleep period or morning. Avoid high-sugar snacks and large meals late at night to reduce the risk of glucose intolerance and elevated triglycerides.

Shift workers often exhibit irregular eating patterns, including increased snacking frequency and reduced intake of dietary fibers, vitamins, and minerals, contributing to nutritional deficiencies.

Ensure your night shift snacks include sources of fiber and micronutrients (like vegetables, whole grains, or supplements if necessary) rather than just high-fat or high-sugar convenience foods. Regularly assess your intake of zinc and vitamins A and D.

The magnitude of depressive symptom reduction from resistance exercise training is larger in individuals with mild to moderate depression compared to those with subclinical symptoms.

If you are experiencing mild to moderate depressive symptoms, resistance exercise training is likely to provide a substantial reduction in those symptoms. While it also helps those with subclinical symptoms, the effect is significantly larger for those with elevated baseline scores.

The observed antidepressant effect of resistance exercise training is smaller in trials where allocation and/or assessment was blinded, indicating that unblinded trials may overestimate the effect due to bias.

Be aware that the large effects often cited in unblinded studies may be inflated by participant expectations. However, even in rigorous, blinded trials, resistance exercise training still produces a significant, moderate reduction in depressive symptoms.

High predicted fat mass is strongly and monotonically associated with increased all-cause, cardiovascular, and cancer mortality in men, whereas low predicted lean body mass is the primary driver of the 'obesity paradox' (increased mortality at low BMI).

For men, maintaining muscle mass is as critical as managing fat for longevity. High fat mass increases mortality risk linearly, while low muscle mass increases risk significantly. Focus on resistance training to preserve lean mass and dietary quality to manage fat, rather than just chasing a specific BMI number.